Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

BACKGROUND Although a majority of patients with amnestic mild cognitive impairment (aMCI) progress to Alzheimer disease, the natural history of nonamnestic MCI (naMCI) is less clear. Noninvasive imaging surrogates for underlying pathological findings in MCI would be clinically useful for identifying patients who may benefit from disease-specific treatments at the prodromal stage of dementia. OBJECTIVE To determine the characteristic magnetic resonance imaging (MRI) and proton MR spectroscopy (1H MRS) profiles of MCI subtypes. DESIGN Case-control study. SETTING Community-based sample at a tertiary referral center. PATIENTS Ninety-one patients with single-domain aMCI, 32 patients with multiple-domain aMCI, 20 patients with single- or multiple-domain naMCI, and 100 cognitively normal elderly subjects frequency-matched by age and sex. MAIN OUTCOME MEASURES Posterior cingulate gyrus 1H MRS metabolite ratios, hippocampal volumes, and cerebrovascular disease on MRI. RESULTS Patients with single-domain aMCI were characterized by small hippocampal volumes and elevated ratios of myo-inositol to creatine levels. Patients with naMCI on average had normal hippocampal volumes and 1H MRS metabolite ratios, but a greater proportion (3 of 20 patients [15%]) had cortical infarctions compared with patients with single-domain aMCI (6 of 91 [7%]). For characterization of MCI subtypes, 1H MRS and structural MRI findings were complementary. CONCLUSIONS The MRI and 1H MRS findings in single-domain aMCI are consistent with a pattern similar to that of Alzheimer disease. Absence of this pattern on average in patients with naMCI suggests that cerebrovascular disease and other neurodegenerative diseases may be contributing to the cognitive impairment in many individuals with naMCI.

[1]  A. Rey.  L'examen clinique in psychologie , 1964 .

[2]  P. O'Brien,et al.  The appropriateness of analysis of variance and multiple-comparison procedures. , 1983, Biometrics.

[3]  O'Brien Pc,et al.  The appropriateness of analysis of variance and multiple-comparison procedures. , 1983 .

[4]  E. Kaplan,et al.  The Boston naming test , 2001 .

[5]  E. Tangalos,et al.  Mayo Clinic Alzheimer’s Disease Patient Registry , 1990, Aging.

[6]  C. Jack,et al.  MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. , 1990, Radiology.

[7]  A. Agresti,et al.  Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.

[8]  Alan Agresti,et al.  Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.

[9]  B. Reisberg,et al.  Mild cognitive impairment in the elderly , 1991, Neurology.

[10]  O. Spreen,et al.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .

[11]  James F. Malec,et al.  Mayo's older americans normative studies: Updated AVLT norms for ages 56 to 97 , 1992 .

[12]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.

[13]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[14]  E. Tangalos,et al.  Neuropsychological tests' norms above age 55: COWAT, BNT, MAE token, WRAT-R reading, AMNART, STROOP, TMT, and JLO , 1996 .

[15]  Walter Kukull,et al.  Progression to dementia in patients with isolated memory loss , 1997, The Lancet.

[16]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[17]  J. Wegiel,et al.  Relationships between Regional Neuronal Loss and Neurofibrillary Changes in the Hippocampal Formation and Duration and Severity of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[18]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[19]  E. Tangalos,et al.  Mayo's older Americans normative studies: category fluency norms. , 1998, Journal of clinical and experimental neuropsychology.

[20]  F Träber,et al.  Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD , 2000, Neurology.

[21]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[22]  C. Jack,et al.  FLAIR histogram segmentation for measurement of leukoaraiosis volume , 2001, Journal of magnetic resonance imaging : JMRI.

[23]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[24]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[25]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[26]  M H Buonocore,et al.  Brain structure and cognition in a community sample of elderly Latinos , 2002, Neurology.

[27]  W. Markesbery,et al.  Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study , 2002, Neurology.

[28]  N. Schuff,et al.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.

[29]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[30]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[31]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[32]  E G Tangalos,et al.  1H MR spectroscopy in common dementias , 2004, Neurology.

[33]  S. Chantal,et al.  Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease , 2004, Brain Research.

[34]  B. L. Miller,et al.  Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients , 2005, Neurology.

[35]  J. Schneider,et al.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.

[36]  R. Egan,et al.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia , 2005 .

[37]  M. Weiner,et al.  Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia , 2005, Annals of neurology.

[38]  D. Harvey,et al.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.

[39]  C. Vergani,et al.  Mild Cognitive Impairment Subtypes and Vascular Dementia in Community‐Dwelling Elderly People: A 3‐Year Follow‐Up Study , 2006, Journal of the American Geriatrics Society.

[40]  Patrizia Mecocci,et al.  Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy , 2006, Neurobiology of Aging.

[41]  J Philip Miller,et al.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI , 2006, Neurology.

[42]  B. Miller,et al.  Subtype of Mild Cognitive Impairment and Progression to Dementia and Death , 2006, Dementia and Geriatric Cognitive Disorders.

[43]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[44]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[45]  S. Riedel-Heller,et al.  Mild cognitive impairment , 2006, Neurology.

[46]  Clifford R Jack,et al.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. , 2007, Brain : a journal of neurology.

[47]  J. Morris,et al.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease , 2001, Journal of Molecular Neuroscience.

[48]  Christine Delmaire,et al.  Prevalence of Subcortical Vascular Lesions and Association With Executive Function in Mild Cognitive Impairment Subtypes , 2007, Stroke.

[49]  T. J. Grabowski,et al.  Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia , 2007 .

[50]  P. Scheltens,et al.  The significance of medial temporal lobe atrophy , 2007, Neurology.

[51]  C. Jack,et al.  Patterns of atrophy differ among specific subtypes of mild cognitive impairment. , 2007, Archives of neurology.

[52]  P. Mecocci,et al.  Vascular Risk Factors in Mild Cognitive Impairment Subtypes , 2007, Dementia and Geriatric Cognitive Disorders.

[53]  W. Krampla,et al.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia , 2007, Neurology.

[54]  Jullie W Pan,et al.  Hippocampal neurochemistry, neuromorphometry, and verbal memory in nondemented older adults , 2008, Neurology.

[55]  D. Bennett,et al.  LONG-TERM FETAL CELL TRANSPLANT IN HUNTINGTON DISEASE: STAYIN’ ALIVE , 2007, Neurology.

[56]  C. Jack,et al.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. , 2008, Radiology.

[57]  C. Jack,et al.  Progressive aphasia secondary to Alzheimer disease vs FTLD pathology , 2008, Neurology.

[58]  Melissa E. Murray,et al.  O1-01-02: Alzheimer's disease with relative hippocampal sparing: A distinct clinicopathologic variant , 2008, Alzheimer's & Dementia.

[59]  C. DeCarli,et al.  O2-01-04: Cerebrovascular disease in mild cognitive impairment , 2008, Alzheimer's & Dementia.

[60]  Norbert Schuff,et al.  Neuropathological basis of magnetic resonance images in aging and dementia , 2008, Annals of neurology.